HomeNewsRespiratoryCOPD

  • NICE advises restricted use of antibiotics for COPD

    • July 10, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Bellerophon to Present Positive Results from Phase 2 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with COPD at ATS Conference

    • May 16, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • AstraZeneca’s Fasenra Fails in Phase III COPD Trial

    • May 11, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Verona Pharma to Present Clinical Trial Data of RPL554 at ATS (American Thoracic Society 2018) Conference

    • May 9, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Verona Pharma to Mark its Presence at BioEquity Europe 2018

    • May 5, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Trelegy Ellipta gains expanded indication in the US for the treatment of patients with COPD

    • April 25, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Novartis updates Launch Timeline for Advair Copy to 2019

    • April 22, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • GSK Appoints Senior Executive from Roche to Accelerate Pipeline Growth

    • April 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Trelegy Ellipta – IMPACT Study Shows Significant Benefits in COPD Patients

    • April 19, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more